New drug combo aims to stop chemo sickness
NCT ID NCT07482891
Summary
This study is testing whether a combination of two anti-nausea drugs (fosrolapitant and palonosetron) can prevent vomiting and nausea in people receiving strong, multi-day chemotherapy for cancer. It will involve 200 adults with solid tumors who are about to start their first round of this type of treatment. The main goal is to see how well the drug combination controls these difficult side effects throughout the entire chemotherapy cycle.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHEMOTHERAPY INDUCED NAUSEA AND VOMITING are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.